Assignee
COMPASS THERAPEUTICS LLC
US15 patents
Top patents by PatentIndex Score
US10716851B2Jul 21, 2020
Agonist antibodies that bind human CD137 and uses thereof
COMPASS THERAPEUTICS LLC10 citations91
US10350292B1Jul 16, 2019
Agonist antibodies that bind human CD137 and uses thereof
COMPASS THERAPEUTICS LLC12 citations91
US10279040B1May 7, 2019
Agonist antibodies that bind human CD137 and uses thereof
COMPASS THERAPEUTICS LLC10 citations91
US10279039B2May 7, 2019
Agonist antibodies that bind human CD137 and uses thereof
COMPASS THERAPEUTICS LLC10 citations91
US10279038B2May 7, 2019
Agonist antibodies that bind human CD137 and uses thereof
COMPASS THERAPEUTICS LLC11 citations91
US10434175B2Oct 8, 2019
Agonist antibodies that bind human CD137 and uses thereof
COMPASS THERAPEUTICS LLC5 citations82
US11970538B2Apr 30, 2024
Multispecific binding constructs against checkpoint molecules and uses thereof
COMPASS THERAPEUTICS LLC1 citations67
US11046769B2Jun 29, 2021
Multispecific binding constructs against checkpoint molecules and uses thereof
COMPASS THERAPEUTICS LLC1 citations67
US12467062B2Nov 11, 2025
Transgenic mouse expressing common human light chain
COMPASS THERAPEUTICS LLC0 citations61
US12286483B2Apr 29, 2025
Method of treating cancer using CD137 antibodies and PD-1 antagonists
COMPASS THERAPEUTICS LLC0 citations61
US11851497B2Dec 26, 2023
CD137 antibodies and tumor antigen-targeting antibodies and uses thereof
COMPASS THERAPEUTICS LLC0 citations61
US11752207B2Sep 12, 2023
Agonist antibodies that bind human CD137 and uses thereof
COMPASS THERAPEUTICS LLC0 citations61
US11718679B2Aug 8, 2023
CD137 antibodies and PD-1 antagonists and uses thereof
COMPASS THERAPEUTICS LLC0 citations61
US12503511B2Dec 23, 2025
Multispecific binding constructs against checkpoint molecules and uses thereof
COMPASS THERAPEUTICS LLC0 citations57
US12460004B2Nov 4, 2025
Antibodies that bind CD277 and uses thereof
COMPASS THERAPEUTICS LLC0 citations51